Seo, Jaein http://orcid.org/0000-0001-6061-4301
Smith, Charlie A.
Thomas, Caitlin
Tervonen, Tommi
Hareendran, Asha
Ford, Janet H.
Stauffer, Virginia L.
Nicholson, Robert A.
Duffy, Kevin Harrison
Tockhorn-Heidenreich, Antje
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 29 April 2021
First Online: 16 June 2021
Declarations
:
: The study was funded by Eli Lilly & Co.
: Jaein Seo, Charlie A. Smith, Caitlin Thomas, Tommi Tervonen, and Asha Hareendran are employees of Evidera, which was paid by Eli Lilly & Co. for work related to this study. Janet H. Ford, Virginia L. Stauffer, Robert A. Nicholson, Kevin Harrison Duffy, and Antje Tockhorn-Heidenreich are employees of Eli Lilly & Co.
: Before any study procedures were initiated, the study was approved by the US central institutional review board of Ethical & Independent Review Services (Independence, MO, USA) (institutional review board reference number 19144-01). This study does not require review by a local ethics committee in the UK and Germany according to the NHS Health Research Authority and the German <i>Medicinal Products Act</i> (<i>Arzneimittelgesetz</i> –AMG). The study was conducted in accordance with the International Council on Harmonization Privacy Statement, the <i>Health Insurance Portability and Accountability Act</i>, and the European <i>General Data Protection Regulation</i> and is reported in accordance with the recommendations of the COnsolidated criteria for REporting Qualitative research (COREQ) Checklist and Standards for Reporting Qualitative Research (SRQR) reporting guidelines and Good Publication Practice 3 guidelines.
: All participants provided verbal and online consent to participate.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are not publicly available as no consent was sought from participants to allow sharing of data with third parties.
: Not Applicable.
: JS contributed to conception and planning of the work, acquisition and interpretation of the data, and drafting and critical revision of the manuscript. CAS contributed to the acquisition, analysis, and interpretation of the data and drafting the manuscript. CT contributed to the conception and planning of the work, acquisition and analysis of the data, and drafting the manuscript. TT contributed to the conception and planning of the work, interpretation of the data, and drafting the manuscript. AH contributed to the conception and planning of the work, data acquisition, and the drafting and critical revision of the manuscript. JHF contributed to the conception and planning of the work and critical revision of the manuscript. VLS contributed to the conception and planning of the work and critical revision of the manuscript. RAN contributed to the conception and planning of the work and critical revision of the manuscript. KHD contributed to the conception and planning of the work and critical revision of the manuscript. AT-H contributed to the conception and planning of the work and critical revision of the manuscript. All participated sufficiently in the work to take public responsibility for the entire content of the manuscript.